[Federal Register Volume 73, Number 148 (Thursday, July 31, 2008)]
[Notices]
[Pages 44772-44773]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17509]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Intersocietal Accreditation Commission

    Notice is hereby given that, on June 25, 2008, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Intersocietal Accreditation 
Commission (``IAC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
(1) the name and

[[Page 44773]]

principal place of business of the standards development organization 
and (2) the nature and scope of its standards development activities. 
The notifications were filed for the purpose of invoking the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: Intersocietal 
Accreditation Commission, Columbia, MD. The nature and scope of IAC's 
standards development activities are: the development of consensus 
standards for quality assurance in diagnostic imaging facilities, thus 
improving the quality of patient care provided in private offices 
clinics and hospitals where such medical tests are provided. The IAC 
develops consensus standards in the following categories: (a) 
Accreditation of vascular laboratories (extracranial cerebrovascular, 
intracranial cerebrovascular, peripheral arterial, peripheral venous, 
visceral vascular, screening), (b) accreditation of echocardiography 
laboratories (adult transthoracic, adult transesophageal, adult stress, 
pediatric transthoracic, pediatric transesophageal, fetal), (c) 
accreditation of nuclear medicine laboratories (nuclear cardiology, 
general nuclear medicine, PET), (d) accreditation of magnetic resonance 
laboratories (body [pelvis, abdomen, chest, and/or breast], 
cardiovascular, musculoskeletal, neurological), and (e) accreditation 
of computed tomography laboratories (cardiovascular, whole body, 
neurological, sinus and temporal bone).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E8-17509 Filed 7-30-08; 8:45 am]
BILLING CODE 4410-11-M